Angiogenic Activity of Mesenchymal Stem Cells in Multiple Myeloma

被引:29
|
作者
Wang, Xiaofang [1 ]
Zhang, Zhiqing [2 ]
Yao, Cheng [3 ]
机构
[1] Tianjin Med Univ, Dept Hematol, Canc Hosp Tianjin, Tianjin 300060, Peoples R China
[2] Dalian Cent Hosp, Dept Neurol, Dalian, Peoples R China
[3] Jilin Univ, Dept Hematol, Hosp 1, Changchun 130023, Peoples R China
关键词
ENDOTHELIAL GROWTH-FACTOR; BONE-MARROW; ANTIANGIOGENESIS;
D O I
10.3109/07357907.2010.496758
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The pathophysiology of multiple myeloma-induced angiogenesis is complex and involves both direct production of angiogenic cytokines by plasma cells and their induction within the microenvironment. In this research, we investigated whether mesenchymal stem cells participated in inducing the angiogenic response in multiple myeloma, and explored the mechanism by which MSCs influence myeloma angiogenesis. We detected the concentration of angiogenic factors (bFGF, HGF, and VEGF) in the conditioned medium of mesenchymal stem cells and the capillary formation ability of mesenchymal stem cells in vitro. We found that conditioned medium of MSCs derived from MM significantly promoted the proliferation, chemotaxis, and capillary formation of human umbilical vein endothelial cells compared with that from normal donors. ELISA and RT-PCR were used to detect the mRNA and protein levels of angiogenic factors (bFGF, HGF, and VEGF) in the conditioned medium. We found that mRNA and protein levels of angiogenic factors were elevated in MSCs from multiple myeloma compared with normal donors.</.
引用
收藏
页码:37 / 41
页数:5
相关论文
共 50 条
  • [11] Abnormalities of bone marrow mesenchymal stem cells in multiple myeloma.
    Wallace, SR
    Oken, MH
    Van Ness, B
    Masellis, AM
    BLOOD, 1999, 94 (10) : 547A - 547A
  • [12] Expansion and characterization of bone marrow mesenchymal stem cells in multiple myeloma
    Tondreau, T.
    Meuleman, N.
    Boufker, H. Id
    Bron, D.
    Lagneaux, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 124 - 124
  • [13] Canine mesenchymal stem cells are neurotrophic and angiogenic: An in vitro assessment of their paracrine activity
    Al Delfi, I. R.
    Sheard, J. J.
    Wood, C. R.
    Vernallis, A.
    Innes, J. F.
    Myint, P.
    Johnson, W. E. B.
    VETERINARY JOURNAL, 2016, 217 : 10 - 17
  • [14] Jagged Ligands Enhance the Pro-Angiogenic Activity of Multiple Myeloma Cells
    Palano, Maria Teresa
    Giannandrea, Domenica
    Platonova, Natalia
    Gaudenzi, Germano
    Falleni, Monica
    Tosi, Delfina
    Lesma, Elena
    Citro, Valentina
    Colombo, Michela
    Saltarella, Ilaria
    Ria, Roberto
    Amodio, Nicola
    Taiana, Elisa
    Neri, Antonino
    Vitale, Giovanni
    Chiaramonte, Raffaella
    CANCERS, 2020, 12 (09) : 1 - 18
  • [15] Impairment in Immunomodulatory Function of Mesenchymal Stem Cells from Multiple Myeloma Patients
    Li, Bingzong
    Fu, Jinxing
    Chen, Ping
    Zhuang, Wenzhuo
    ARCHIVES OF MEDICAL RESEARCH, 2010, 41 (08) : 623 - 633
  • [16] Anti-Angiogenic Activity of Drugs in Multiple Myeloma
    Saltarella, Ilaria
    Altamura, Concetta
    Campanale, Carmen
    Laghetti, Paola
    Vacca, Angelo
    Frassanito, Maria Antonia
    Desaphy, Jean-Francois
    CANCERS, 2023, 15 (07)
  • [17] Angiogenic and Immunomodulatory Properties of Endothelial and Mesenchymal Stem Cells
    Bartaula-Brevik, Sushma
    Pedersen, Torbjorn O.
    Finne-Wistrand, Anna
    Bolstad, Anne Isine
    Mustafa, Kamal
    TISSUE ENGINEERING PART A, 2016, 22 (3-4) : 244 - 252
  • [18] Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway
    Ikiru Atsuta
    Shiyu Liu
    Yasuo Miura
    Kentaro Akiyama
    Chider Chen
    Ying An
    Songtao Shi
    Fa-Ming Chen
    Stem Cell Research & Therapy, 4
  • [19] Natural killer cells and bone marrow mesenchymal stem cells: A dangerous liaison in multiple myeloma
    Botana, Iria Fernandez
    Moussay, Etienne
    Paggetti, Jerome
    CLINICAL AND TRANSLATIONAL DISCOVERY, 2022, 2 (03):
  • [20] Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway
    Atsuta, Ikiru
    Liu, Shiyu
    Miura, Yasuo
    Akiyama, Kentaro
    Chen, Chider
    An, Ying
    Shi, Songtao
    Chen, Fa-Ming
    STEM CELL RESEARCH & THERAPY, 2013, 4